The SURPASS-CVOT trial is a phase 3, randomized, double-blind cardiovascular outcomes trial that will assess tirzepatide for both non-inferiority and superiority against dulaglutide. For dulaglutide, this effect is already proven: According to the Trulicity website, the drug may be used in adults with type 2 diabetes to reduce the risk of major cardiovascular events (problems having to do with the heart and blood vessels) such as death, heart attack, or stroke in people who have heart disease or multiple cardiovascular risk factors. How do I know which medication is right for me
Gaspari Nutrition Liquid Carnitine 3200 Cola Soda Gaspari Nutrition Liquid Carnitine 3200 Cola Soda Product Images Other information Content details Last updated on 27 Jul 2026 | 01:07 AM (IST) Manufacturer details Name: A)Gaspari Nutra, LLC Address: A)Gaspari Nutra, LLC, 1-8470-001-100, USA Marketer details Name: Gaspari Nutrition Address: 575 Prospect St
Retatrutide is a triple agonist (GLP-1, GIP, glucagon)
Gut bacteria break down fibre into short-chain fatty acids, which stimulate the release of the GLP-1 hormone
10% weight-loss guarantee requires weekly weigh-ins, monthly check-ins, and Facebook group participation to qualify